ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 200692 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 200692; 2) Community: the network communities that were significantly associated with the response to NSC 200692; 3) Molecule: the relationships between components within communities and NSC 200692; 4) MDR: the compounds that were significantly associated with the NSC 200692.

NSC Compound Enrichment Correlation
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.00265144454581183 -0.36179792
NSC 79093 5-Hydroxy-6,7,8,4'-tetramethoxyflavone 0.00265144454581183 -0.32652063
NSC 12161 Adenosine, 1,2-dihydro-2-oxo- (9CI) 0.00286159651545682 -0.17144487
NSC 382386 2,4-Imidazolidinedione, 3,3'-(1,6-hexanediyl)bis[5,5- diphenyl- 0.00286159651545682 0.44859344
NSC 629868 Null 0.00286159651545682 0.40926532
NSC 636009 Crotoxin CD 0.00286159651545682 0.32292006
NSC 654379 ANTINEOPLASTIC-654379 0.00286159651545682 -0.41005218
NSC 674455 (Z)-1-iodo-2-phenyl-1-penten-3-one 0.00286159651545682 -0.26377038
NSC 676769 Null 0.00286159651545682 -0.35035416
NSC 679002 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl]-, diethyl ester, cis- 0.00286159651545682 -0.28505634
Total:83  Current:9    [First] [Prev] [Next] [Last]